Key points are not available for this paper at this time.
This report describes real-world comparisons of survival, the average number of doses administered, the presence of postnaloxone signs and symptoms, and hospital transport refusal among people receiving 8-mg and 4-mg intranasal naloxone.
Payne et al. (Thu,) studied this question.